A Randomised Phase II Study of Roginolisib in Patients With Advanced/Metastatic Uveal Melanoma
Clinical trial NCT06717126 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06717126
- Sponsor
- iOnctura
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-27
- Primary completion
- 2027-12-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.